Fast screening and structural elucidation of G-quadruplex ligands from a mixture via G-quadruplex recognition and NMR methods

Biochimie

Volumn 91, Issue 2, 2009, Pages 304-308

  Zhou, Qiuju ^a,b   Li, Lin ^a   Xiang, Junfeng ^a   Sun, Hongxia ^a   Tang, Yalin ^a  

^a PEKING UNIVERSITY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOPHENONES; ASCORBIC ACID; BERBERINE; BUFFERS; CIRCULAR DICHROISM; COMPUTER SIMULATION; G-QUADRUPLEXES; HYDROGEN-ION CONCENTRATION; LIGANDS; MOLECULAR STRUCTURE; MORPHINANS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PLANT EXTRACTS; PROTONS;

EID: 58849091291     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2008.10.011     Document Type: Article

References (28)

1. Patel D.J., Phan A.T., and Kuryavyi V. Human telomere, oncogenic promoter and 5′-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics. Nucleic Acids Res. 35 (2007) 7429-7455
2. Simonsson T., Pecinka P., and Kubista M. DNA tetraplex formation in the control region of c-myc. Nucleic Acids Res. 26 (1998) 1167-1172
3. Hurley L.H. DNA and its associated processes as targets for cancer therapy. Nat. Rev. Cancer 2 (2002) 188-200
4. Siddiqui-Jain A., Grand C.L., Bearss D.J., and Hurley L.H. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 11593-11598
5. Mergny J.L., and Helene C. G-quadruplex DNA: a target for drug design. Nat. Med. 4 (1998) 1366-1367
6. Zahler A.M., Williamson J.R., Cech T.R., and Prescott D.M. Inhibition of telomerase by G-quartet DNA structures. Nature 350 (1991) 718-720
7. Mergny J.L., Mailliet P., Lavelle F., Riou J.F., Laoui A., and Helene C. The development of telomerase inhibitors: the G-quartet approach. Anticancer Drug Des. 14 (1999) 327-339
8. Lim J.K.C., Rice W.G., Schwaebe M.K., Siddiqui-Jain A., Trent K.B., Whitten P., Hurley L.H., and von Hoff D.D. Clinical development of CX-3543, a novel multi-targeting antitumor agent. J. Clin. Oncol. 23 (2005) 242s
9. Ricart A.D., Papadopoulos K.P., Von Hoff D.D., Lim J.K.C., and Marschke R.F. A phase I and pharmacokinetic (PK) study of CX-3543, a protein-rDNA quadruplex inhibitor, in patients (pts) with advanced solid tumors. EJC Suppl. 4 (2006) 111
10. Papadopoulos K., Mita A., Ricart A., Hufnagel D., Northfelt D., Von Hoff D., Darjania L., Lim J., Padgett C., and Marschke R. Pharmacokinetic findings from the phase I study of Quarfloxin (CX-3543): a protein-rDNA quadruplex inhibitor, in patients with advanced solid tumors. Mol. Cancer Ther. 6 (2007) 3462s-3463s
11. Bejugam M., Sewitz S., Shirude P.S., Rodriguez R., Shahid R., and Balasubramanian S. Trisubstituted isoalloxazines as a new class of G-quadruplex binding ligands: small molecule regulation of c-kit oncogene expression. J. Am. Chem. Soc. 129 (2007) 12926-12927
12. Tauchi T., Shin-ya K., Sashida G., Sumi M., Okabe S., Ohyashiki J.H., and Ohyashiki K. Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia. Oncogene 25 (2006) 5719-5725
13. Balandrin M.F., Klocke J.A., Wurtele E.S., and Bollinger W.H. Natural plant chemicals: sources of industrial and medicinal materials. Science 228 (1985) 1154-1160
14. Newman D.J., and Cragg G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 70 (2007) 461-477
15. Corson T.W., and Crews C.M. Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell 130 (2007) 769-774
16. Koeppel F., Riou J.F., Laoui A., Mailliet P., Arimondo P.B., Labit D., Petitgenet O., Helene C., and Mergny J.L. Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes. Nucleic Acids Res. 29 (2001) 1087-1096
17. Gomez D., Mergny J.L., and Riou J.F. Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay. Cancer Res. 62 (2002) 3365-3368
18. Rosu F., De Pauw E., Guittat L., Alberti P., Lacroix L., Mailliet P., Riou J.F., and Mergny J.L. Selective interaction of ethidium derivatives with quadruplexes: an equilibrium dialysis and electrospray ionization mass spectrometry analysis. Biochemistry 42 (2003) 10361-10371
19. Ladame S., Whitney A.M., and Balasubramanian S. Targeting nucleic acid secondary structures with polyamides using an optimized dynamic combinatorial approach. Angew. Chem.-Int. Ed. 44 (2005) 5736-5739
20. Naasani I., Seimiya H., Yamori T., and Tsuruo T. FJ5002: a potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis. Cancer Res. 59 (1999) 4004-4011
21. Franceschin M., Rossetti L., D'Ambrosio A., Schirripa S., Bianco A., Ortaggi G., Savino M., Schultes C., and Neidle S. Natural and synthetic G-quadruplex interactive berberine derivatives. Bioorg. Med. Chem. Lett. 16 (2006) 1707-1711
22. Wang Y., and Patel D.J. Solution structure of a parallel-stranded G-quadruplex DNA. J. Mol. Biol. 234 (1993) 1171-1183
23. Sun H., Xiang J., Tang Y., and Xu G. Regulation and recognization of the extended G-quadruplex by rutin. Biochem. Biophys. Res. Commun. 352 (2007) 942-946
24. Gavathiotis E., Heald R.A., Stevens M.F., and Searle M.S. Drug recognition and stabilisation of the parallel-stranded DNA quadruplex d(TTAGGGT)4 containing the human telomeric repeat. J. Mol. Biol. 334 (2003) 25-36
25. Gavathiotis E., Heald R.A., Stevens M.F.G., and Searle M.S. Recognition and stabilization of quadruplex DNA by a potent new telomerase inhibitor: NMR studies of the 2:1 complex of a pentacyclic methylacridinium cation with d(TTAGGGT)(4). Angew. Chem.-Int. Ed. 40 (2001) 4749-4751
26. Lin M., Shapiro M.J., and Wareing J.R. Diffusion-edited NMR-affinity NMR for direct observation of molecular interactions. J. Am. Chem. Soc. 119 (1997) 5249-5250
27. Lin M., Shapiro M.J., and Wareing J.R. Screening mixtures by affinity NMR. J. Org. Chem. 62 (1997) 8930-8931
28. Hodge P., Monvisade P., Morris G.A., and Preece I. A novel NMR method for screening soluble compound libraries. Chem. Commun. (2001) 239-240